Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

18.46 -0.34 (-1.81%)
Official Closing Price Updated: 7:00 PM EDT, Aug 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
29 30 Next >
Dow Rises 150 Points As Fed Boosts Rates By 0.75 Percentage Points
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
Nasdaq Jumps Over 300 Points; Boeing Posts Wider-Than-Expected Loss
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday. 
Via Benzinga
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits
Teva Pharmaceuticals (TEVA) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits. 
Via InvestorPlace
Why Teva Pharmaceutical Industries Stock Is Soaring
Teva Pharmaceutical Industries (NYSE: TEVA) shares are trading higher Wednesday after the company reported better-than-expected financial results. 
Via Benzinga
Teva Pharmaceutical Soars On $75 Million Opioid Deal In West Virginia
Teva will also provide the state with free opioid overdose treatment for a decade. 
Via Investor's Business Daily
What Is Going on With Teva Pharmaceuticals (TEVA) Stock Today?
TEVA stock, already trading far below its prior peak, may come under pressure in the near future due to the threat of ongoing litigation. 
Via InvestorPlace
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital... 
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Analyst Ratings for Teva Pharmaceutical Indus
Within the last quarter, Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings: 
Via Benzinga
Teva Announces $4.25b Opioid Agreement With States, Native American Tribes
Teva has reached an agreement in principle with the working group of States' Attorneys General, counsel for Native American Tribes, and plaintiffs' lawyers representing the States and subdivisions, on... 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
Reuters Monkeypox Emergency Could Last Months, According To Experts 
Via Benzinga
Alphabet, Microsoft And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Pzena Investment Management, Inc (NYSE: PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on! 
Via InvestorPlace
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session
Gainers Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Why Teva Pharmaceuticals Stock Is Soaring After Hours
Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results. 
Via Benzinga
Teva Reports Second Quarter 2022 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
7 Growth Stocks to Buy on the Dip
These are the best growth stocks to buy on the dip. A, CDNS, GXTG, IVSG, IQV, PAYX, and SNPS are poised to deliver impressive returns. 
Via InvestorPlace
Will Bed Bath & Beyond (BBBY) Stock Really Fall to $1?
Bed Bath & Beyond (BBBY) stock is in the news today after an incredibly bearish analyst said the retailer's shares will fall to $1 a piece. 
Via InvestorPlace
Teva Reaches Agreement With San Francisco to Settle Opioid-Related Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report
Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY 
Via Benzinga
Teva Announces Appointment of New Global R&D and Chief Medical Officer
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)
From Teva Pharmaceutical Industries Ltd.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
Upgrades 
Via Benzinga
Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute
From Teva Pharmaceutical Industries Limited
Via Business Wire
New Real-World Data Evaluating AJOVY® (fremanezumab-vfrm) Injection Use in Patients With Migraine Presented at 2022 American Headache Society Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.